Production (Stage)
Sensus Healthcare, Inc.
SRTS
$4.69
$0.010.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -36.14% | 47.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -36.14% | 47.82% | |||
| Cost of Revenue | -33.05% | 65.60% | |||
| Gross Profit | -38.73% | 35.61% | |||
| SG&A Expenses | 15.06% | 32.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.09% | 54.41% | |||
| Operating Income | -253.30% | 15.45% | |||
| Income Before Tax | -225.87% | 10.26% | |||
| Income Tax Expenses | -73.17% | -26.65% | |||
| Earnings from Continuing Operations | -266.36% | 27.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -266.36% | 27.24% | |||
| EBIT | -253.30% | 15.45% | |||
| EBITDA | -241.36% | 16.99% | |||
| EPS Basic | -266.38% | 27.15% | |||
| Normalized Basic EPS | -225.94% | 10.16% | |||
| EPS Diluted | -269.13% | 35.14% | |||
| Normalized Diluted EPS | -226.61% | 9.73% | |||
| Average Basic Shares Outstanding | 0.05% | 0.08% | |||
| Average Diluted Shares Outstanding | -0.60% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||